Alerts will be sent to your verified email
Verify Email
INNOVACAP
|
Innova Captab
|
Supriya Lifescience
|
Aarti Drugs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
20.73 % | 29.47 % | 19.9 % |
|
5yr Avg Net Profit Margin
|
8.55 % | 24.83 % | 8.4 % |
|
Price to Book
|
5.54 | 5.35 | 3.15 |
|
P/E
|
40.97 | 29.95 | 22.88 |
|
5yr Avg Cash Conversion Cycle
|
31.3 Days | 10.2 Days | 82.62 Days |
|
5yr Average Interest Coverage Ratio
|
22.73 | 36.33 | 9.51 |
|
5yr Avg ROCE
|
21.99 % | 37.03 % | 22.85 % |
|
5yr Avg Operating Profit Margin
|
13.36 % | 34.97 % | 14.52 % |
|
5 yr average Debt to Equity
|
0.55 | 0.17 | 0.49 |
|
5yr CAGR Net Profit
|
30.09 % | 10.17 % | 3.93 % |
|
5yr Average Return on Assets
|
8.63 % | 18.81 % | 9.61 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
50.9 % | 68.3 % | 55.22 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.06 % | -4.76 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
7.22 % | -2.44 % | 7.17 % |
|
Innova Captab
|
Supriya Lifescience
|
Aarti Drugs
|
|---|